Research on nitric oxide-releasing nanoparticles reveals viable skin infection treatment

July 31, 2017

WASHINGTON (July 31, 2017) -- George Washington University (GW) researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by dermatophytes, for which the current standard of care is treatment with systemic antifungals.

Dermatophytosis, or ringworm, is a fungal infection of the skin, hair, or nails that affects millions of people around the world. While superficial infections can often be managed with topical agents, fungal infections which infiltrate the hair follicle or into deeper layers of the skin can only be effectively treated with oral or systemic antifungal therapies. Topical antifungals offer limited penetration through the skin.

"Systemic antifungals, while effective, can come with some baggage, given the duration of treatment can be lengthy. They are also known for their ability to adversely interact with many commonly used medications such as blood thinners and anti-hypertensives, or even cause various side effects themselves," said Adam Friedman, MD, associate professor of dermatology at the GW School of Medicine and Health Sciences and senior author of the study. "The purpose of this study was to explore whether nanotechnology -- materials that are billionths of a meter -- could be used to overcome need for systemic medications, which would ultimately be safer and easier on the patient."

Friedman and collaborators at the Albert Einstein College of Medicine turned to nitric oxide, a natural, gaseous immunomodulator with broad-spectrum, multi-faceted antimicrobial activity, as the ideal agent for treatment.

"While we have known for decades that nitric oxide has tremendous potential in so many areas of medicine, its use has been limited due to the lack of effective delivery systems," Friedman said. "Here we used a well-studied nanoparticle that can actually make nitric oxide, not just release it, and deliver therapeutic levels over time to attack these deep and difficult to reach infections."

In an animal model, the research team found that NO-np facilitated a quicker, more impactful response to treatment over the commercially available topical terbinafine, showing 95 percent of infection clearance by the third day of treatment. These findings are in line with multiple previous reports utilizing the NO-np against fungal and bacterial surgical wound and burn infection.

"The next step is to scale up the technology for clinical trial use in several therapeutic areas given the diverse clinical implications of the nitric oxide producing nanoformulation, as well as the platform overall given its unique ability to encapsulate and deliver a broad range of active ingredients," Friedman explained. "Dermatophyte infections impact such a large, diverse population, so it's important to find new treatments that are safe and more effective for all patients."
-end-
"Topical Nitric Oxide Releasing Nanoparticles are Effective in a Murine Model of Dermal Trichophyton rubrum Dermatophytosis" in Nanomedicine: Nanotechnology, Biology, and Medicine is available at http://www.nanomedjournal.com/article/S1549-9634(17)30127-2/abstract

Media: To interview Dr. Friedman, please contact Ashley Rizzardo at amrizz713@gwu.edu or 202-994-8679.

About the GW School of Medicine and Health Sciences:

Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nation's capital and is the 11th oldest in the country. Working together in our nation's capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national and global communities. smhs.gwu.edu

George Washington University

Related Fungal Infections Articles from Brightsurf:

Boron nitride nanofilms for protection from bacterial and fungal infections
NUST MISIS material scientists have presented antibacterial nano-coatings based on boron nitride, which are highly effective against microbial pathogens (up to 99.99%).

New research on how fungal cells respond to stress
Numerous species of filamentous fungi are pathogens that can make people sick, especially people who are immunocompromised.

Development of novel oral formulation to treat systemic fungal infections
The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc.

Study unravels how our immune system deals with fungal and viral infections
The body's immune response to fungal infections changes when a patient is also infected by a virus, according to new research which investigated the two types of infection together for the first time.

Fungal decisions can affect climate
Research shows fungi may slow climate change by storing more carbon.

Fungal diversity and its relationship to the future of forests
Stanford researchers predict that climate change will reduce the diversity of symbiotic fungi that help trees grow.

Probiotic yeast may offer an effective treatment for drug-resistant fungal infections
Researchers at Worcester Polytechnic Institute (WPI) & the Central Food Technological Research Institute in India are studying the effect of probiotic yeast in preventing fungal infections.

'Fungal feature tracker' could accelerate mycology research
A new software tool called Fungal Feature Tracker could accelerate understanding of fungal morphology and growth.

UMD discovers new mechanism in the liver that helps prevent invasive fungal infections
An expert in intravital microscopy, Meiqing Shi, University of Maryland, is making breakthroughs in invasive fungal infections.

For hospitalized patients with fungal infections, specialists save lives
Fungal bloodstream infections are responsible for the deaths of more than 10,000 people every year.

Read More: Fungal Infections News and Fungal Infections Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.